ID,CONSIDERATION,DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
X73-150,,Anticoagulants,Acenocoumarol,"VKORC1CYP2C9","Significantly increasedacenocoumarol sensitivity",DPWG
X73-150,,,Warfarin,"VKORC1CYP2C9","Significantly increased warfarinsensitivity",FDA4
X73-150,,Antiepileptics,Phenytoin,CYP2C9,Adverse effects,CPIC5
X73-150,,Antiplatelet drugs,Clopidogrel,CYP2C19,Reduced / inadequate response,CPIC2
X73-150,,"Angiotensin receptorblockers",Irbesartan,CYP2C9,"Increased therapeutic and/oradverse effects",-
X73-150,,"Antidepressants -other",Moclobemide,CYP2C19,Adverse effects,-
X73-150,,Antidepressants -,Citalopram,CYP2C19,Adverse effects,CPIC6
X73-150,,SSRIs,Escitalopram,CYP2C19,Adverse effects,CPIC6
X73-150,,,Sertraline,CYP2C19,Adverse effects,CPIC6
X73-150,,"Antidepressants -tricyclicantidepressants",Amitriptyline,"CYP2D6CYP2C19",Altered response,CPIC7
X73-150,,,Clomipramine,"CYP2D6CYP2C19",Altered response,CPIC7
X73-150,,,Doxepin,"CYP2D6CYP2C19",Altered response,CPIC7
X73-150,,,Imipramine,"CYP2D6CYP2C19",Altered response,CPIC7
X73-150,,Antidiabetics,Gliclazide,"CYP2C9CYP2C19","Increased therapeutic and/oradverse effects",-
X73-150,,,Glimepiride,CYP2C9,"Increased therapeutic and/oradverse effects",-
X73-150,,,Glyburide,CYP2C9,"Increased therapeutic and/oradverse effects",-
X73-150,,Antifungals - Azoles,Voriconazole,CYP2C19,"Increased therapeutic and/oradverse effects",CPIC8
X73-150,,Antipsychotics,Quetiapine,CYP3A4,Adverse effects,-
X73-150,,Benzodiazepines,Clobazam,CYP2C19,Adverse effects,-
X73-150,,,Diazepam,CYP2C19,Adverse effects,-
X73-150,,Miscellaneous,Cyclophosphamide,CYP2C19,Reduced / inadequate response,-
X73-150,,,Proguanil,CYP2C19,Reduced / inadequate response,-
X73-150,,NSAIDs,Celecoxib,CYP2C9,"Increased therapeutic and/oradverse effects",-
X73-150,,,Flurbiprofen,CYP2C9,Adverse effects,-
X73-150,,,Ibuprofen,CYP2C9,Adverse effects,-
X73-150,,,Meloxicam,CYP2C9,Adverse effects,-
X73-150,,,Piroxicam,CYP2C9,Adverse effects,-
X73-150,,Opioid Analgesics,Morphine,OPRM1,"Associated with reducedresponse to morphine",-
X73-150,,"Proton pumpinhibitors",Dexlansoprazole,CYP2C19,"Increased therapeutic and/oradverse effects",FDA9
X73-150,,,Esomeprazole,CYP2C19,"Increased therapeutic and/oradverse effects",-
X73-150,,,Lansoprazole,CYP2C19,"Increased therapeutic and/oradverse effects",-
X73-150,,,Omeprazole,CYP2C19,"Increased therapeutic and/oradverse effects",-
X73-150,,,Pantoprazole,CYP2C19,"Increased therapeutic and/oradverse effects",-
X73-150,,,Rabeprazole,CYP2C19,"Increased therapeutic and/oradverse effects",-
X73-150,,Statins,Atorvastatin,"SLCO1B1CYP3A4","Increased therapeutic and/oradverse effects",-
X73-150,,,Simvastatin,"SLCO1B1CYP3A4","Increased therapeutic andadverse effects",CPIC10
X73-150,,"ADHD -miscellaneous agents",Atomoxetine,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,"Angiotensin receptorblockers",Losartan,CYP2C9,"No altered effect predicted bygenotype",-
X73-150,,Antiarrhythmics,Flecainide,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,,Propafenone,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,"Anticholinergics(genitourinary)",Darifenacin,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,,Fesoterodine,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,,Tolterodine,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,Anticholinesterases,Donepezil,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,,Galantamine,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,"Antidepressants -other",Mirtazapine,"CYP2D6CYP1A2","No altered effect predicted bygenotype",-
X73-150,,,Vortioxetine,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,"Antidepressants -serotoninnoradrenalinereuptake inhibitors",Duloxetine,"CYP2D6CYP1A2","No altered effect predicted bygenotype",-
X73-150,,,Venlafaxine,CYP2D6,"No altered effect predicted bygenotype",DPWG11
X73-150,,"Antidepressants -SSRIs",Fluoxetine,"CYP2D6CYP2C9","No altered effect predicted bygenotype",-
X73-150,,,Fluvoxamine,"CYP2D6CYP1A2","No altered effect predicted bygenotype",CPIC6
X73-150,,,Paroxetine,CYP2D6,"No altered effect predicted bygenotype",CPIC6
X73-150,,"Antidepressants -tricyclicantidepressants",Desipramine,CYP2D6,"No altered effect predicted bygenotype",CPIC7
X73-150,,,Nortriptyline,CYP2D6,"No altered effect predicted bygenotype",CPIC7
X73-150,,Antiemetics,Metoclopramide,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,,Ondansetron,CYP2D6,"No altered effect predicted bygenotype",CPIC12
X73-150,,Antihistamines,Chlorpheniramine,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,,Dexchlorpheniramine,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,,Promethazine,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,Antipsychotics,Aripiprazole,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,,Brexpiprazole,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,,Chlorpromazine,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,,Clozapine,CYP1A2,"No altered effect predicted bygenotype",-
X73-150,,,Haloperidol,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,,Olanzapine,CYP1A2,"No altered effect predicted bygenotype",-
X73-150,,,Pimozide,CYP2D6,"No altered effect predicted bygenotype",
X73-150,,,Risperidone,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,,Zuclopenthixol,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,Antitussives,Dextromethorphan,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,Beta blockers,Carvedilol,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,,Metoprolol,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,,Nebivolol,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,,Propranolol,"CYP2D6CYP1A2","No altered effect predicted bygenotype",-
X73-150,,Calcineurin inhibitors,Tacrolimus,CYP3A5,"No altered effect predicted bygenotype",CPIC13
X73-150,,"Glaucoma - ocularpreparations",Timolol,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,Hypnotics,Melatonin,CYP1A2,"No altered effect predicted bygenotype",-
X73-150,,"Immunomodulatorsand antineoplastics",Tamoxifen,CYP2D6,"No altered effect predicted bygenotype",CPIC14
X73-150,,Miscellaneous,Atazanavir,CYP3A5,"No altered effect predicted bygenotype",-
X73-150,,,Eliglustat,CYP2D6,"No altered effect predicted bygenotype",TGA15
X73-150,,,Naltrexone,OPRM1,"No altered effect predicted bygenotype for naltrexone",
X73-150,,Neurological drugs,Tetrabenazine,CYP2D6,"No altered effect predicted bygenotype",FDA16
X73-150,,NSAIDs,Diclofenac,CYP2C9,"No altered effect predicted bygenotype",-
X73-150,,,Indomethacin,CYP2C9,"No altered effect predicted bygenotype",-
X73-150,,,Mefenamic Acid,CYP2C9,"No altered effect predicted bygenotype",-
X73-150,,Opioid Analgesics,Codeine,"CYP2D6OPRM1","Associated with reducedsensitivity to codeine",CPIC3
X73-150,,,Hydrocodone,CYP2D6,"No altered effect predicted bygenotype",
X73-150,,,Oxycodone,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,,Tramadol,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,Psychostimulants,Dextroamphetamine,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,,Lisdexamfetamine,CYP2D6,"No altered effect predicted bygenotype",-
X73-150,,Statins,Fluvastatin,"SLCO1B1CYP2C9","No altered effect predicted bygenotype",-
X73-150,,,Pravastatin,SLCO1B1,"No altered effect predicted bygenotype",-
X73-150,,,Rosuvastatin,SLCO1B1,"No altered effect predicted bygenotype",-
